Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.

Saved in:
Bibliographic Details
Title: Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.
Authors: Pfisterer, Nikolaus1,2,3 (AUTHOR), Schwarz, Michael1,2 (AUTHOR), Schwarz, Caroline1,2,4 (AUTHOR), Putre, Florian1,2 (AUTHOR), Ritt, Lukas1,2 (AUTHOR), Riedl, Florian1,2 (AUTHOR), Hartl, Lukas1,2 (AUTHOR), Jachs, Mathias1,2 (AUTHOR), Mandorfer, Mattias1,2 (AUTHOR), Madl, Christian3,5 (AUTHOR), Trauner, Michael1 (AUTHOR), Reiberger, Thomas1,2,6 (AUTHOR) thomas.reiberger@meduniwien.ac.at
Source: PLoS ONE. 6/13/2024, Vol. 19 Issue 6, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0302811